OM Outset Medical

Outset Medical to Present at BofA Securities 2021 Virtual Health Care Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that members of management will participate in a fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 11:45am PT / 2:45pm ET.

A live and archived webcast of the fireside chat will be available on the “Investors” section of the Outset website at .

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

EN
27/04/2021

Underlying

OMOutset Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Outset Medical

 PRESS RELEASE
Free
OM OUTSET MEDICAL

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Res...

Outset Medical Reports Fourth Quarter and Full Year 2025 Financial Results SAN JOSE, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter, Year-End and Recent Highlights Net revenue totaled $28.9 million in the fourth quarter, bringing revenue in 2025 to $119.5 million, a 5% increase over $113.7 million in 2024.Recurring revenu...

February 11, 2026 1 EN
 PRESS RELEASE
Free
OM OUTSET MEDICAL

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Seco...

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned Tablo becomes first dialysis system to clear FDA’s most rigorous cybersecurity standards SAN JOSE, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) of its next-generation Tablo platform, designed to deliver enterprise-level security, reliability ...

January 27, 2026 1 EN
 PRESS RELEASE
Free
OM OUTSET MEDICAL

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wedn...

Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026 SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the fourth quarter and full-year 2025 after the close of trading on Wednesday, February 11, 2026. On the same day, at 1:30 p.m. Pacific time (4:30 p.m. Eastern time), Leslie Trigg, Chair and Chief Executive Officer, and Rene...

January 26, 2026 1 EN
 PRESS RELEASE
Free
OM OUTSET MEDICAL

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results

Outset Medical Reports Unaudited Fourth Quarter and 2025 Results Appoints Medical Technology Veteran Karen N. Prange to Board of Directors SAN JOSE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2025, and named Karen N. Prange to its board of directors. Unaudited Fourth Quarter and 2025 Results Revenue in the fourth quarter totaled approximately $28.9 milli...

January 12, 2026 1 EN
 PRESS RELEASE
Free
OM OUTSET MEDICAL

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Co...

Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference SAN JOSE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that Chair & CEO Leslie Trigg will present at the 44th annual J.P. Morgan Healthcare conference on Wednesday, January 14, 2026, at 4:30 p.m. Pacific time. A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at . About O...

January 5, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch